Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 28.8.2024Zentiva k.s. (ZNT-3)9619CKalcizen (tbl flm 90x600 mg/400 IU (blis.PVC/Al))3.9.2024O
 28.8.2024Zentiva, k.s. (ZNT-1)7767DPosaconazole Zentiva (tbl ent 24x100 mg (blis.PVC/PE/PVDC/Al))3.9.2024O
 28.8.2024Zentiva, k.s. (ZNT-1)9420DHeparoid Léčiva (crm der 1x100 g (tuba Al))3.9.2024O
 27.8.2024Zentiva k.s. (ZNT-3)02420Pancreolan FORTE (tbl ent 30x220 mg (blis.PVC/PVDC/Al))28.8.2024R
 27.8.2024Zentiva k.s. (ZNT-3)1288APancreolan FORTE (tbl ent 60x220 mg (blis.PVC/PVDC/Al))28.8.2024R
 27.8.2024Teva B.V. (TEV-NL-4)8588BAtomoxetine Actavis 18 mg (cps dur 28x18 mg (blis.PVC/PVDC/PVC/Al))1.11.2024R
 27.8.2024Teva B.V. (TEV-NL-4)58792Ecobec 100 µg (aer ora 200x100 µg/1 dávka (obal Al tlak.+aplik.))9.9.2024R
 27.8.2024Teva B.V. (TEV-NL-4)58793Ecobec 250 µg (aer ora 200x250 µg/1 dávka (obal Al tlak.+aplik.))9.9.2024R
 27.8.2024Teva B.V. (TEV-NL-4)91364Gabapentin-Teva 100 mg (cps dur 100x100 mg (blis.PVC/PVDC/Al))27.10.2024R
 27.8.2024Teva B.V. (TEV-NL-4)37942Ciprofloxacin-Teva 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PVC/PVDC/Al))10.9.2024R
 27.8.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)0997DSorafenib Teva 200 mg (tbl flm 112x200 mg (blis.PVC/Aclar/PVC/Al))2.9.2024O
 27.8.2024URSAPHARM Arzneimittel GmbH (URS-1)2658EPosiforlid 20 mg/g očná masť (ung oph 1x 5 g/100 mg (tuba Al))2.9.2024U
 27.8.2024Bayer, spol. s r.o. (BAY-SK-2)83059Clarinase Repetabs (tbl plg 14x5 mg (blis.OPA/Al/PE/LDPE/Al))19.8.2024R
 26.8.2024B.Braun Melsungen AG (BME)0018AParacetamol B. Braun 10 mg/ml (sol inf 10x50 ml/500 mg (fľ.LDPE))26.8.2024R
 26.8.2024Berlin-Chemie AG (BCE)40021Zofaril 7,5 mg (tbl flm 28x7,5 mg (blis.PVDC/PVC/Al))8.8.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)